Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -38.55% is 65% above its 5-year average of -108.74%, near the high end of its 5-year range (-437.24%–-21.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 30.48% above its 12-month average of -55.45%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -38.55%.
RETURN ON EQUITY (ROE)
-38.55%
RETURN ON EQUITY (ROE) AVG TTM
-55.45%
RETURN ON EQUITY (ROE) AVG 3Y
-112.51%
RETURN ON EQUITY (ROE) AVG 5Y
-108.74%
RETURN ON EQUITY (ROE) AVG 10Y
-159.53%
RETURN ON EQUITY (ROE) AVG 15Y
-113.48%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+30.48%
CURRENT VS 3Y AVG
+65.74%
CURRENT VS 5Y AVG
+64.55%
CURRENT VS 10Y AVG
+75.83%
CURRENT VS 15Y AVG
+66.03%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.76%
median of 689 covered companies
CURRENT VS SECTOR MEDIAN
+5.42%
vs the sector median at left
iBio, Inc.
Market Cap
$67.52M
Return on Equity (ROE)
-38.55%
TTM Avg
-55.45%
3Y Avg
-112.51%
5Y Avg
-108.74%
Market Cap
$67.93M
Return on Equity (ROE)
68.12%
TTM Avg
-94.32%
3Y Avg
-166.28%
5Y Avg
-128.51%
Market Cap
$65.85M
Return on Equity (ROE)
-35.13%
TTM Avg
-26.80%
3Y Avg
-19.63%
5Y Avg
-14.70%
Market Cap
$69.31M
Return on Equity (ROE)
-250.39%
TTM Avg
-122.53%
3Y Avg
-92.00%
5Y Avg
-67.18%
Market Cap
$69.19M
Return on Equity (ROE)
16.70%
TTM Avg
-67.07%
3Y Avg
-43.48%
5Y Avg
-55.81%
Market Cap
$65.86M
Return on Equity (ROE)
-122.71%
TTM Avg
-558.46%
3Y Avg
-307.41%
5Y Avg
-314.14%
Market Cap
$65.15M
Return on Equity (ROE)
-8.80%
TTM Avg
-13.04%
3Y Avg
-7.69%
5Y Avg
-7.21%
Market Cap
$64.77M
Return on Equity (ROE)
N/A
TTM Avg
-26.44%
3Y Avg
-559.66%
5Y Avg
-417.87%
Market Cap
$70.16M
Return on Equity (ROE)
-29.15%
TTM Avg
47.40%
3Y Avg
90.52%
5Y Avg
62.16%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iBio, Inc. (IBIO) | $67.52M | -38.55% | -55.45% | -112.51% | -108.74% |
| Fortress Biotech, Inc. (FBIO)vs › | $67.93M | 68.12% | -94.32% | -166.28% | -128.51% |
| XBiotech Inc. (XBIT)vs › | $65.85M | -35.13% | -26.80% | -19.63% | -14.70% |
| MindWalk Holdings Corp. (HYFT)vs › | $69.31M | -250.39% | -122.53% | -92.00% | -67.18% |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.19M | 16.70% | -67.07% | -43.48% | -55.81% |
| Cingulate Inc. (CING)vs › | $65.86M | -122.71% | -558.46% | -307.41% | -314.14% |
| InterCure Ltd. (INCR)vs › | $65.15M | -8.80% | -13.04% | -7.69% | -7.21% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.77M | N/A | -26.44% | -559.66% | -417.87% |
| Champions Oncology, Inc. (CSBR)vs › | $70.16M | -29.15% | 47.40% | 90.52% | 62.16% |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.56M | -492.89% | -50.27% | -279.07% | -249.48% |
ROE
-38.6%
ROA
-33.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -38.55% |
| 2026-03-31 | -35.60% |
| 2025-12-31 | -43.74% |
| 2025-09-30 | -35.88% |
| 2025-06-30 | -123.50% |
| 2025-03-31 | -184.45% |
| 2024-12-31 | -138.92% |
| 2024-09-30 | -130.39% |
| 2024-06-30 | -116.80% |
| 2024-03-31 | -93.16% |
| 2023-12-31 | -296.66% |
| 2023-09-30 | -398.41% |
| 2023-06-30 | -422.66% |
| 2023-03-31 | -437.24% |
| 2022-12-31 | -431.00% |
| 2022-09-30 | -123.00% |
| 2022-06-30 | -79.24% |
| 2022-03-31 | -41.74% |
| 2021-12-31 | -31.35% |
| 2021-09-30 | -24.48% |
| 2021-06-30 | -21.37% |
| 2021-03-31 | -25.62% |
| 2020-12-31 | -22.24% |
| 2020-09-30 | -24.37% |
| 2020-06-30 | -29.03% |
| 2020-03-31 | -438.83% |
| 2019-06-30 | -714.29% |
| 2019-03-31 | -253.48% |
| 2018-12-31 | -155.63% |
| 2018-09-30 | -127.98% |
| 2018-06-30 | -99.62% |
| 2018-03-31 | -385.56% |
| 2017-12-31 | -204.39% |
| 2017-09-30 | -243.08% |
| 2017-06-30 | -163.02% |
| 2017-03-31 | -99.49% |
| 2016-12-31 | -289.02% |
| 2016-09-30 | -154.32% |
| 2016-06-30 | -98.26% |
| 2016-03-31 | -108.55% |
| 2015-12-31 | -96.64% |
| 2015-09-30 | -71.57% |
| 2015-06-30 | -58.99% |
| 2015-03-31 | -57.71% |
| 2014-12-31 | -57.32% |
| 2014-09-30 | -100.31% |
| 2014-06-30 | -60.12% |
| 2014-03-31 | -54.88% |
| 2013-12-31 | -54.32% |
| 2013-09-30 | -66.30% |
| 2013-06-30 | -122.28% |
| 2013-03-31 | -271.71% |
| 2012-12-31 | -204.04% |
| 2012-09-30 | -177.44% |
| 2012-06-30 | -92.02% |
| 2012-03-31 | -86.03% |
| 2010-12-31 | -540.38% |
| 2010-06-30 | -564.80% |
| 2010-03-31 | -110.34% |
| 2009-12-31 | -50.90% |
| 2009-09-30 | -43.56% |
| 2009-06-30 | -43.43% |
| 2009-03-31 | -42.42% |
| 2008-12-31 | -43.32% |
| 2008-09-30 | -35.41% |
